mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
0.24 |
0.2 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |